Basic Clin Pharmacol Toxicol
August 2019
Proton pump inhibitors (PPIs) are prodrugs used in the treatment of peptic ulcer diseases. Once activated by acidic pH, the PPIs subsequently inhibit the secretion of gastric acid by covalently forming disulphide bonds with the SH groups of the parietal proton pump, that is the H /K -ATPase. Long-term use of PPIs has been associated with numerous adverse effects, including bone fractures.
View Article and Find Full Text PDF